Hochmair, Maximilian J.
Buder, Anna
Schwab, Sophia
Burghuber, Otto C.
Prosch, Helmut
Hilbe, Wolfgang
Cseh, Agnieszka
Fritz, Richard
Filipits, Martin
Article History
First Online: 12 December 2018
Compliance with Ethical Standards
:
: Maximilian J. Hochmair has received honoraria from AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Merck Sharp & Dohme, Pfizer, and Roche and had consulting or advisory roles with Boehringer Ingelheim, Merck Sharp & Dohme, Novartis, and Roche. Anna Buder has received honoraria from AstraZeneca. Helmut Prosch has received honoraria from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Merck Sharp & Dohme, Novartis, and Roche and has received a research grant from Boehringer Ingelheim. Wolfgang Hilbe has received advisory board and lecture fees from Boehringer Ingelheim. Agnieszka Cseh and Richard Fritz are employees of Boehringer Ingelheim. Martin Filipits has received honoraria from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp & Dohme, Novartis, Ratiopharm, and Roche. Sophia Schwab, and Otto C. Burghuber declare that they have no conflicts of interest that might be relevant to the contents of this manuscript.
: Medical writing assistance, supported financially by Boehringer Ingelheim, was provided by Katharine Williams and Lynn Pritchard of GeoMed, an Ashfield company, part of UDG Healthcare plc, during the development of this manuscript. Open access publication of this article was funded by Boehringer Ingelheim.